EyePoint Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

EyePoint

07/03/2024 15:36

* EyePoint Pharmaceuticals Inc  EYPT.OQ  reported a
quarterly
adjusted loss of 33 cents​​ per share for the quarter ended in
December, higher than the same quarter last year, when the
company reported EPS of $-1.16.  The mean expectation of
eleven analysts for the quarter was for a loss of 49 cents per
share. Wall Street expected results to range from -76 cents
to -29 cents per share.
    * Revenue rose 33.2% to $14.03 million from a year ago;
analysts
expected $8.90 million. 
    * EyePoint Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 33 cents​.
    * The company reported a quarterly loss of $14.1 million.
    * EyePoint Pharmaceuticals Inc shares had risen by 11.4%
this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for EyePoint
Pharmaceuticals Inc is $46.00 
This summary was machine generated from LSEG data March 7 at
03:36 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.49          -0.33          Beat
 Sep. 30 2023      -0.51          -0.33          Beat
 Jun. 30 2023      0.60           -0.61          Missed
 Mar. 31 2023      -0.68          -0.56          Beat